Randomized comparison of second trimester pregnancy termination utilizing saline moistened or dry misoprostol

Basit Öğe Kaydı
dc.authorscopusid57193697138
dc.authorscopusid55891544100
dc.authorscopusid8506771000
dc.authorscopusid15728637200
dc.authorscopusid6603267445
dc.authorscopusid8878400800
dc.authorscopusid15727484600
dc.contributor.authorYilmaz B.
dc.contributor.authorKelekci S.
dc.contributor.authorErtas I.E.
dc.contributor.authorOzel M.
dc.contributor.authorSut N.
dc.contributor.authorMollamahmutoglu L.
dc.contributor.authorDanisman N.
dc.date.accessioned2024-06-12T10:24:57Z
dc.date.available2024-06-12T10:24:57Z
dc.date.issued2007
dc.description.abstractObjective: The aim of this randomized prospective study was to compare efficacy and side effects of saline moistened misoprostol with dry misoprostol, administered 800 ?g intravaginally every 6 h up to a maximum of 3 doses in 24 h for second trimester pregnancy termination. Materials and methods: A total of 81 women seeking termination of second trimester pregnancy (55 fetal death, 17 fetal structural anomaly, 5 chromosomal abnormality, 4 other reasons) were randomly assigned to one of two treatment groups: (1) intravaginal non-moistened (dry) misoprostol in group A (n = 40) or (2) misoprostol moistened with 3 ml of saline in group B (n = 41). Results: All of the patients in either group aborted within 48 h (100% success rate). Delivery was achieved in a median (interquartile range) of 13 (40) h with the group A protocol and 12 (36) h with the group B protocol (P = 0.652). Delivery with first dose, delivery within 12 h and delivery within 24 h were similar (P > 0.05) in group B (34.1, 87.5 and 60%, respectively) and group A (25, 82.9, 46.3, respectively). Both treatment regimens were tolerable and with similar side effects. Conclusion: Misoprostol moistened with saline was not more effective than dry misoprostol for second trimester pregnancy termination. © 2007 Springer-Verlag.en_US
dc.identifier.doi10.1007/s00404-007-0374-9
dc.identifier.endpage516en_US
dc.identifier.issn0932-0067
dc.identifier.issue5en_US
dc.identifier.pmid17453221en_US
dc.identifier.scopus2-s2.0-34548662218en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage511en_US
dc.identifier.urihttps://doi.org/10.1007/s00404-007-0374-9
dc.identifier.urihttps://hdl.handle.net/20.500.14551/16108
dc.identifier.volume276en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.relation.ispartofArchives of Gynecology and Obstetricsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDry; Misoprostol; Moistened; Saline; Second Trimester Pregnancy Terminationen_US
dc.subjectMisoprostol; Sodium Chloride; Adult; Article; Chill; Chromosome Aberration; Clinical Trial; Comparative Study; Controlled Clinical Trial; Controlled Study; Diarrhea; Drug Effect; Drug Efficacy; Female; Fetus Death; Human; Major Clinical Study; Nausea; Pregnancy Termination; Prospective Study; Randomized Controlled Trial; Second Trimester Pregnancy; Vomiting; Abortifacient Agents; Abortion, Therapeutic; Administration, Intravaginal; Adult; Female; Humans; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Sodium Chloride; Treatment Outcomeen_US
dc.titleRandomized comparison of second trimester pregnancy termination utilizing saline moistened or dry misoprostolen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu